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Body Mass Index and Sudden Cardiac Death in Japanese Patients
After Acute Myocardial Infarction: Data From the JCAD Study and
HIJAMI-II Registry
Tsuyoshi Shiga, MD; Takahide Kohro, MD; Hiro Yamasaki, MD; Kazutaka Aonuma, MD; Atsushi Suzuki, MD; Hiroshi Ogawa, MD;
Nobuhisa Hagiwara, MD; Tsutomu Yamazaki, MD; Ryozo Nagai, MD; Hiroshi Kasanuki, MD
Background-—Although an “obesity paradox” exists in patients after myocardial infarction, the association between obesity and
the risk of sudden cardiac death (SCD) is limited. The aim of this study was to determine whether obesity is associated with an
increased risk of SCD in Japanese survivors of acute myocardial infarction.
Methods and Results-—Pooled data from 2 cohort studies in Japan, JCAD (Japanese Coronary Artery Disease) study and the Heart
Institute of Japan Acute Myocardial Infarction-II (HIJAMI-II) registry, comprising of 6216 patients (mean age 6511 years, 75.2%
male) with acute myocardial infarction who were discharged alive, were studied. The patients were categorized into the following
body mass index (BMI) groups at baseline according to the World Health Organization classiﬁcation for Asian populations: BMI
<18.5 kg/m2 (n=335), 18.5 to 23 kg/m2 (n=2371), 23 to 27.5 kg/m2 (n=2823), and ≥27.5 kg/m2 (n=687). The main outcomes
were all-cause mortality and SCD. During an average follow-up period of 3.61.4 years, all-cause mortality was 10.1%, and SCD
was 1.2%. Patients with BMI <18.5 kg/m2 had the highest rate of all-cause mortality (adjusted hazard ratio, 1.61; 95% conﬁdence
interval, 1.20–2.16), but high BMI (≥27.5 kg/m2) was not associated with mortality compared with patients in the group with BMI
≥18.5 and <23 kg/m2. However, the long-term risk of SCD was increased in the group with BMI ≥27.5 kg/m2 (adjusted hazard
ratio, 2.97; 95% conﬁdence interval, 1.24–7.15). Multivariate analysis revealed that BMI ≥27.5 kg/m2 was associated with an
increased risk of SCD (hazard ratio, 2.78; 95% conﬁdence interval, 1.35–5.74).
Conclusions-—Obesity (BMI ≥27.5 kg/m2) was associated with the risk of SCD in Japanese patients after myocardial infarction,
although an obesity paradox was found for all-cause mortality. ( J Am Heart Assoc. 2018;7:e008633. DOI: 10.1161/JAHA.118.
008633.)
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O besity is an important predictor of myocardial infarction(MI) and mortality in the general population.1,2 However,
several studies have revealed an obesity paradox in patients
after MI: low body mass index (BMI) is associated with
mortality in high-risk patients with MI in the primary
percutaneous coronary intervention era.3–5 Sudden cardiac
death (SCD) is one of the major causes of death in patients
with coronary artery disease (CAD) and MI.6 Recent large
population-based cohort studies have reported that higher
BMI is associated with an increased risk of SCD, although
these ﬁndings are controversial.7,8 Data on the association
between obesity and the risk of SCD and ventricular
tachyarrhythmias in patients with MI are limited.9–11 More-
over, whether obese patients who survive an acute MI have a
long-term risk of SCD is unclear.
The World Health Organization (WHO) expert consultation
recommended that the cutoff point for obesity be 27.5 kg/m2
or higher for the Asian population because Asian individuals
have different associations between BMI, body fat, and health
risks than individuals in the United States and Europe.12 The
NIPPON DATA 80 study group and Asia Cohort Consortium
BMI Project also support the World Health Organization
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proposal that the BMI cutoff for obesity should be ≥27.5 kg/m2
for the Asian population.13,14
The aim of this study was to evaluate whether obesity, as
deﬁned by BMI ≥27.5 kg/m2, is associated with an increased
risk of SCD in Japanese survivors of MI using data from the
combined cohorts of the JCAD (Japanese Coronary Artery
Disease) study and the Heart Institute of Japan Acute
Myocardial Infarction-II (HIJAMI-II) registry.
Methods
The data, analytic methods, and study materials will not be
made available to other researchers for purposes of repro-
ducing the results or replicating the procedure.
Study Population
Pooled patient data were obtained from the JCAD study and
HIJAMI-II registry. The JCAD study is an observational cohort
study designed to investigate the risk factors and status of
the medical management of Japanese CAD patients. The study
design, objectives, and criteria for the eligibility and exclusion
of patients are described in detail elsewhere.15 Brieﬂy,
13 812 consecutive patients undergoing coronary angiogra-
phy who were diagnosed as having 75% or higher stenosis in
at least 1 branch of the coronary arteries, according to the
American Heart Association classiﬁcation, were enrolled from
217 participating hospitals in Japan between 2000 and 2001
and were followed up for a mean period of 2.7 years.16 The
HIJAMI-II registry is an observational cohort study designed to
determine the incidence of SCD according to the left
ventricular ejection fraction (LVEF) in Japanese survivors of
MI. The study design, objectives, and recruitment of study
participants are described in detail elsewhere.17 Brieﬂy, 4122
patients with acute MI who were discharged alive from 18
participating hospitals in Japan between 1999 and 2002 were
enrolled immediately and were followed up for a mean period
of 4.1 years. The JCAD protocol was approved by the Central
Institutional Review Board of the University of Tokyo. The
HIJAMI-II registry protocols were approved by the institutional
review boards of each participating hospital. Written informed
consent was obtained from each study participant.
In the JCAD study, 2955 of the 13 812 enrolled patients
had suffered an acute MI at the time of registration. After data
were combined, the total population of the 2 studies
comprised 7077 patients. Of 2955 JCAD patients with acute
MI, the LVEF measurement was not available for 834 (28%)
patients. Data on the clinical and angiographic characteristics
were not available for 27 (0.7%) of the 4122 HIJAMI-II
patients. The total population of the 2 studies comprised
6216 patients.
Exposure Assessment
In these studies, the baseline demographic values, weights,
and heights of all patients were recorded to calculate BMI as
weight in kilogramsdividedbyheight inmeters squared (kg/m2).
Patients were divided into 4 prespeciﬁed BMI groups using
the World Health Organization classiﬁcation for Asian popu-
lations: BMI <18.5 kg/m2 denoted underweight, 18.5 to
23 kg/m2 denoted an increasing but acceptable risk, 23 to
27.5 kg/m2 denoted an increased risk, and ≥27.5 kg/m2
denoted a high risk.12
LVEF was obtained from the baseline database of both
studies containing the results of ventriculography, echocar-
diography, or radionuclide ventriculography, performed before
hospital discharge.15,17
Outcome Assessment
The prespeciﬁed outcomes in this study were all-cause
mortality and SCD. To standardize the deﬁnition of SCD in
this analysis of the combined studies, all fatal cases were
reviewed and adjudicated by a committee of investigators
(H.Y., T.K., T.S., and K.A.). Deﬁnite SCD was deﬁned as
sudden, unexpected death attributable to a cardiac cause
such as a sudden cardiac arrest in a previously stable
individual. Possible SCD was deﬁned as unexpected, endoge-
nous death within 24 hours after last having been seen alive
that was not related to a speciﬁc cause of circulatory failure
or a cause other than the heart. In this study, deﬁnite SCD
and possible out-of-hospital SCD were included as SCD.
Clinical Perspective
What Is New?
• Our study demonstrated a U-shaped relationship between
body mass index and risk of sudden cardiac death in
Japanese patients after acute myocardial infarction,
although an “obesity paradox” existed for all-cause
mortality.
• In addition, our study showed obese patients (body mass
index ≥27.5 kg/m2) exhibited an increased long-term risk
of sudden cardiac death.
What Are the Clinical Implications?
• Our ﬁndings suggest that a substantial reassessment is
needed of the importance of obesity for sudden cardiac
death prevention in patients after myocardial infarction and
that obese patients with myocardial infarction should be
encouraged to pursue weight-loss strategies.
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Determination of LVEF
LVEF was calculated from the results of ventriculography,
echocardiography, or radionuclide ventriculography per-
formed during hospitalization due to acute MI. All LVEF
determinations were performed by independent investigators
(T.K. and A.S.) who were blinded to the patients’ data.
Statistical Analysis
Data are presented as the meanstandard deviation and
median with the interquartile range or frequency. One-way
ANOVA was used to compare groups with respect to normally
distributed continuous variables, and the Kruskal-Wallis test
was used for other variables. Categorical variables were
subjected to chi-squared analysis. Cumulative probabilities
of all-cause mortality and SCD were estimated with the
Kaplan-Meier method from enrollment data and by means of a
comparison of cumulative events based on BMI with the log-
rank test. To evaluate the inﬂuence of BMI on subsequent
death events, unadjusted and adjusted Cox proportional
hazards models were evaluated according to BMI group: BMI
<18.5, 18.5 to 23, 23 to 27.5, and ≥27.5 kg/m2. The Cox
model was adjusted for age, sex, risk factors, LVEF, and
medications. The proportionality assumption was checked by
inspection of the log-log plots. Univariate and multivariate
analyses using the Cox model were performed to determine
the relationships between the BMI group and SCD, indepen-
dent of the following confounders: age, sex, each coronary risk
factor, LVEF, coronary revascularization, and each medication.
A forward stepwise method was used for the multivariate
analyses, with entry or removal based on a P<0.10.
Two-tailed P<0.05 were considered to indicate a statisti-
cally signiﬁcant difference. Data analyses were performed
using SPSS statistical software (version 11.01, SPSS Inc,
Chicago, IL, USA).
Results
Of 6216 MI survivors, 86.4% received coronary revasculariza-
tion during their hospitalization. During an average follow-up
of 3.61.4 years, the rate of all-cause mortality was 10.1%
and the rate of SCD was 1.2%. In this study, the mean BMI
was 23.63.3 kg/m2, and the median BMI was 23.4 kg/m2
(interquartile range, 21.5–25.6) (Figure 1). The patient distri-
bution according to BMI was as follows: 5.4% had a BMI of
<18.5 kg/m2, 38.1% had a BMI of 18.5 to 23 kg/m2, 45.4%
had a BMI of 23 to27.5 kg/m2, and 11.1% had a BMI of
≥27.5 kg/m2.
The patients’ baseline characteristics are shown in Table 1.
Patients with a BMI of ≥27.5 kg/m2 were younger and had
higher LVEF and systolic and diastolic blood pressure values.
The incidences of complicated coronary risk factors such as
hypertension, dyslipidemia, diabetes mellitus, smoking, and a
family history of CAD were higher in this group of patients.
With regard to medications at discharge, use of aspirin,
angiotensin-converting enzyme inhibitors/angiotensin II
receptor blockers, b-blockers, statins, and calcium channel
blockers were more frequent in this group.
Kaplan-Meier curves for all-cause mortality in the 4 groups
are shown in Figure 2. There was a signiﬁcantly lower
incidence of all-cause mortality in patients with a BMI of
23.5 to 27.5 kg/m2 and ≥27.5 kg/m2 compared with the
others (P<0.001). Kaplan-Meier curves for SCD-free status in
the 4 groups are shown in Figure 3. There was a signiﬁcantly
higher incidence of SCD in patients with a combined BMI
<18.5 and ≥27.5 kg/m2 compared with the others (P=0.005).
The unadjusted Cox proportional hazards model demon-
strated an increased risk of 3-year all-cause death in the
lowest BMI group (BMI <18.5 kg/m2) and a U-shaped
relationship between BMI and the risk of 3-year SCD, with
an increased risk in both patients with a BMI of <18.5 kg/m2
and those with a BMI of ≥27.5 kg/m2 (Table 2). After
adjusting for age, sex, risk factors, LVEF, and medications,
the risk of SCD was signiﬁcantly higher in patients with a BMI
of ≥27.5 kg/m2 (adjusted hazard ratio, 2.97, 95% conﬁdence
interval, 1.24–7.15) compared with those with a BMI of 18.5
to 23 kg/m2 (Table 2).
Multivariate analysis revealed that a BMI of ≥27.5 kg/m2
was associatedwith an increased risk of SCD (hazard ratio 2.78,
95% conﬁdence interval, 1.35–5.74; P=0.006), which was
independent of LVEF ≤30% and multivessel disease (Table 3).
Discussion
Our study revealed an obesity paradox in Japanese patients
who survived an acute MI, whereby low BMI (<18.5 kg/m2)
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Figure 1. Distribution of body mass index (BMI) among 6216
patients with acute myocardial infarction who were discharged
alive.
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was associated with the highest rate of all-cause mortality and
high BMI (≥27.5 kg/m2) was not associated with mortality. A
U-shaped relationship between BMI and the risk of SCD exists
in Japanese patients after acute MI. After a multivariable
adjustment, patients with high BMI (≥27.5 kg/m2) had an
increased risk of SCD compared with those with a BMI of 18.5
to 23 kg/m2. Furthermore, our results suggested that high
BMI is a risk factor of SCD independent of LVEF.
Obesity is a metabolic disorder and an important and well-
established risk factor for cardiovascular disease, including
Figure 2. Kaplan-Meier curve for all-cause death in patients
with myocardial infarction by body mass index (BMI) groups.
Table 1. Baseline Patient Characteristics by BMI Category
BMI <18.5 (n=335) BMI 18.5 to 22.9 (n=2371) BMI 23.0 to 27.4 (n=2823) BMI ≥27.5 (n=687) P Value
BMI, kg/m2 17.31.1 21.21.2 24.81.2 29.62.3 <0.0001
Age, y 7311 6811 6411 5912 <0.0001
Male 182 (54) 1724 (73) 2239 (79) 530 (77) <0.0001
Smoker 160 (48) 1276 (54) 1673 (59) 411 (60) <0.0001
Hypertension 165 (49) 1178 (50) 1629 (58) 465 (68) <0.0001
Diabetes mellitus 98 (29) 781 (33) 1042 (37) 310 (45) <0.0001
Dyslipidemia 81 (24) 900 (38) 1351 (48) 418 (61) <0.0001
Family history of CAD 42 (13) 337 (14) 480 (17) 134 (20) 0.0007
Systolic BP, mm Hg 12825 12924 13125 13624 <0.0001
Diastolic BP, mm Hg 7214 7415 7615 8015 <0.0001
LVEF, % 5114 5213 5313 5312 0.0168
Multivessel disease 153 (46) 1103 (47) 1273 (45) 297 (43) 0.5059
Left main lesion 7 (2) 54 (2) 51 (2) 6 (1) 0.1123
Coronary revascularization 264 (79) 2031 (86) 2483 (89) 597 (87) <0.0001
Medications at discharge
Aspirin 295 (88) 2137 (90) 2574 (91) 687 (100) 0.0664
ACE inhibitors/ARBs 183 (55) 1539 (65) 2016 (71) 500 (73) <0.0001
b-Blockers 108 (32) 780 (33) 1045 (37) 290 (42) <0.0001
Statins 53 (16) 618 (26) 927 (33) 268 (39) <0.0001
Calcium channel blockers 97 (29) 673 (28) 844 (30) 265 (39) <0.0001
Nitrates 207 (62) 1318 (56) 1583 (56) 384 (56) 0.2018
Values are meanSD or n (%). ACE indicates angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; BMI, body mass index; BP, blood pressure; CAD, coronary artery disease;
LVEF, left ventricular ejection fraction.
Figure 3. Kaplan-Meier curve for sudden cardiac death in
patients with myocardial infarction by body mass index (BMI)
groups.
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CAD, in the general population; obesity is also associated with
increased cardiovascular and with all-cause morbidity and
mortality.18 Obese patients with acute MI are younger and
have a higher incidence of risk factors and higher LVEF
compared with nonobese patients.3,5,9,19 For the primary
prevention of CAD, obesity is recognized as a potent risk
factor and an opportunity for therapeutic intervention to
prevent cardiovascular disease. However, recent reports have
shown that obesity (high BMI) itself does not present a
mortality risk but is associated with a better prognosis
(obesity paradox) in CAD patients receiving secondary care;
these patients received appropriate therapy, including percu-
taneous coronary intervention and guideline-based medica-
tions, such as aspirin, b-blockers, and statins.3–5,18,19 Our
study also observed the obesity paradox, and patients with a
BMI of ≥27.5 kg/m2 also received several cardiovascular
drugs.
Das et al19 reported that extreme obesity is independently
associated with higher in-hospital mortality in patients with
ST-segment elevation MI as found through the analysis of a
large registry. Romero-Corral et al4 performed a meta-
analysis of 40 cohort studies of patients with CAD and
reported that a U-shaped interaction existed between BMI and
cardiovascular mortality but not total mortality and that
mortality increased in patients who were extremely obese
(BMI ≥35 kg/m2). These results indicate that obesity remains
a risk factor for cardiovascular mortality, including SCD, in
patients with CAD despite their younger ages, better LV
function, and receipt of optimal therapy.
The reason obese patients have a risk of SCD after MI
despite these advantages is not well understood. Recently,
Eranti et al20 reported that overweight and obese patients
were at increased risk for SCD in a general population of
10 543 middle-aged subjects. Obesity itself may contribute to
the development of arrhythmogenic substrates in the ventri-
cle. Obesity is reported to be independently associated with
LV hypertrophy, which leads to cardiac structural and
functional remodeling.21 An autopsy study of 28 obese
patients (22 SCDs) revealed LV dilatation, severe coronary
atherosclerosis, and concentric LV hypertrophy and histolog-
ically conﬁrmed cardiomyocyte hypertrophy in these
patients.22 Some reports have shown QT prolongation or an
increased late potential in obese patients.23–25 An autonomic
disturbance was reported in obese patients,26 which may
provoke arrhythmia.
Reduced LVEF is the best available predictor of SCD in
survivors of MI. In this study, a high BMI was a risk factor of
SCD independent of LVEF. A subanalysis of the MADIT-II
(Multicenter Automatic Deﬁbrillator Implantation Trial II)
included high-risk patients with a previous MI and LVEF
≤30% and reported that an independent inverse association
existed between the BMI values and risk of all-cause mortality
and SCD.9 In the MADIT-II, patients were randomized to
receive a prophylactic implantable cardioverter-deﬁbrillator or
conventional medical therapy at a 3:2 ratio. In patients with
an implantable cardioverter-deﬁbrillator, however, obesity
(BMI ≥30 kg/m2) was a signiﬁcant risk factor for ventricular
tachyarrhythmias requiring appropriate implantable
Table 3. Multivariate Risk Ratios for 3-Year Sudden Cardiac
Death
Risk Ratio (95% CI) P Value
Age (1-year increase) 1.02 (0.99–1.05) 0.106
Family history of CAD 0.33 (0.10–1.08) 0.067
LVEF ≤30% 2.51 (1.06–5.96) 0.038
Multivessel disease 4.27 (2.11–8.64) <0.001
BMI <18.5 1.65 (0.57–4.76) 0.353
BMI ≥27.5 2.78 (1.35–5.74) 0.006
BMI indicates body mass index; CAD, coronary artery disease; CI, conﬁdence interval;
LVEF, left ventricular ejection fraction.
Table 2. Unadjusted and Adjusted 3-Year All-Cause Mortality and Sudden Cardiac Death
BMI <18.5 (n=335) BMI 18.5 to 22.9 (n=2371) BMI 23.0 to 27.4 (n=2823) BMI ≥27.5 (n=687)
All-cause mortality (%) 69 (20.6) 202 (8.5) 149 (5.3) 30 (4.4)
Hazard ratio (95% CI)
Unadjusted 2.60 (1.98–3.42) 1 (reference) 0.61 (0.49–0.75) 0.50 (0.34–0.73)
Adjusted* 1.61 (1.20–2.16) 1 (reference) 0.79 (0.63–0.99) 0.81 (0.54–1.23)
Sudden cardiac death (%) 6 (1.8) 17 (0.7) 22 (0.8) 11 (1.6)
Hazard ratio (95% CI)
Unadjusted 2.65 (1.05–6.73) 1 (reference) 1.07 (0.57–2.01) 2.17 (1.02–4.63)
Adjusted* 2.45 (0.88–6.81) 1 (reference) 0.92 (0.45–1.85) 2.97 (1.24–7.15)
BMI indicates body mass index; CI, conﬁdence interval.
*Adjusted for age, sex, risk factors, left ventricular ejection fraction, and medications.
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cardioverter-deﬁbrillator therapy.10 From these results, obe-
sity might contribute to the development of tachyarrhythmia,
which can lead to SCD, in high-risk patients after MI.
Multivessel disease was found to be an independent risk
factor for SCD in this study. Multivessel disease is a well-
known risk factor of mortality in patients with MI.27 A small
study showed that multivessel disease was not a predictor of
long-term SCD in MI patients who received reperfusion
therapy,28 but there are few data on whether multivessel
disease is a risk factor for SCD.
In this study, only 1.2% of patients experienced SCD after
acute MI. Primary percutaneous coronary intervention in
acute MI is central to optimal ST-elevation MI treatment and
reduces infarct size, minimizes myocardial damage, preserves
LV function, and decreases morbidity and mortality.29 Early
revascularization contributes to an improvement in LV func-
tion after acute MI, and this improvement will lead to better
survival, including decreasing SCD. In our study, 86.4% of
patients received early coronary revascularization during
hospitalization due to acute MI. Currently, most patients with
acute MI received early coronary revascularization, such as
primary percutaneous coronary intervention, and a low
incidence of SCD has been reported in patients with acute
MI who receive primary percutaneous coronary intervention in
the United States and Europe,29,30 as well as in Japan.17
Our ﬁndings indicated that obese patients who survive an
acute MI have a long-term risk of SCD. Although lifestyle
modiﬁcations and medical therapies or implantable car-
dioverter-deﬁbrillators may inhibit SCD, we could not deter-
mine whether intentional weight loss was effective in the
prevention of SCD or in the reduction of risk in obese patients
with MI. To make these determinations, further investigations
are needed.
Study Limitations
This study had some limitations. First, the present study used
data from 2 past registries and thus could not account for
confounders, such as frailty, cognitive impairment, chronic
obstructive pulmonary disease, and peripheral artery disease,
that were not contained in either database. In addition,
analysis of the groups located at both ends of the distribution
of BMI, low (<18.5 kg/m2) and high (≥27.5 kg/m2), was
limited by the small number of subjects. However, the 2
conﬁrmatory methods, Kaplan-Meier analysis and multivariate
adjustment, that were employed in the present study
consistently indicated an association between high BMI and
risk of SCD in patients after MI in both cohorts. Second,
longitudinal measurements of body weight and LVEF were not
performed to evaluate the improvement in LV function after
MI. Third, treatment bias existed because this was an
observational study. b-Blocker use was limited in this study.
The original data were obtained between 1999 and 2002.
Fourth, information about culprit and other vessels on
coronary angiography was not fully available, so we could
not assess the possible role of an organic coronary stenosis
lesion in LVEF or subsequent death.
Conclusions
Our study demonstrated a U-shaped relationship between BMI
and risk of SCD in Japanese patients after acute MI, although
an obesity paradox existed for all-cause mortality. Obese
patients (BMI ≥27.5 kg/m2) exhibited an increased long-term
risk of SCD. Our ﬁndings suggest that a substantial reassess-
ment is needed of the importance of obesity for SCD
prevention in patients after MI and that obese patients with
MI should be encouraged to pursue weight-loss strategies.
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